Cargando…
Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis
PURPOSE: Thromboembolism is a common adverse event in women treated with tamoxifen (TAM) for breast cancer. The risk in male breast cancer patients is poorly investigated. We aimed to examine the risk of thrombotic events after TAM in male breast cancer patients. PATIENTS AND METHODS: In this prospe...
Autores principales: | Eggemann, Holm, Bernreiter, Anna-Lena, Reinisch, Mattea, Loibl, Sibylle, Taran, Florin-Andrei, Costa, Serban-Dan, Ignatov, Atanas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353985/ https://www.ncbi.nlm.nih.gov/pubmed/30655614 http://dx.doi.org/10.1038/s41416-018-0369-2 |
Ejemplares similares
-
Survival benefit of tamoxifen in male breast cancer: prospective cohort analysis
por: Eggemann, Holm, et al.
Publicado: (2020) -
Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen
por: Ignatov, Atanas, et al.
Publicado: (2020) -
The impact of G protein-coupled oestrogen receptor 1 on male breast cancer: a retrospective analysis
por: Maiwald, Jan-Hendrik, et al.
Publicado: (2021) -
BCL3 expression is strongly associated with the occurrence of breast cancer relapse under tamoxifen treatment in a retrospective cohort study
por: Czapiewski, Piotr, et al.
Publicado: (2022) -
Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials
por: Loibl, Sibylle, et al.
Publicado: (2008)